Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Otterson

Showing results (61-70 of 157) with videos related to

Pageof 16
Sort By:
Clinical Lung Cancer|September 11, 2018
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung CancerDwight H Owen, Lai Wei, Erin M Bertino, et al.
The Journal of Biological Chemistry|January 15, 2004
5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferationWei-Guo Zhu, Theresa Hileman, Yang Ke, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective AnalysisChristian L Barney, Nicholas Scoville, Eric Allan, et al.
Diagnostic Pathology|December 12, 2013
Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumorsKonstantin Shilo, Xin Wu, Smita Sharma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancerRebecca S Heist, Xiaofei Wang, Lydia Hodgson, et al.
Human Pathology|April 22, 2014
Y-chromosome status identification suggests a recipient origin of posttransplant non-small cell lung carcinomas: chromogenic in situ hybridization analysisWei Chen, Sergey V Brodsky, Weiqiang Zhao, et al.
Methods (San Diego, Calif.)|October 5, 2010
The search for an optimal DNA, RNA, and protein detection by in situ hybridization, immunohistochemistry, and solution-based methodsFengting Yan, Xin Wu, Melissa Crawford, et al.
International Journal of Environmental Research and Public Health|August 27, 2014
Clinical and metabolic parameters in non-small cell lung carcinoma and colorectal cancer patients with and without KRAS mutationsAhmet Yilmaz, Nehad Mohamed, Kara A Patterson, et al.
Cancer|October 2, 2012
Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohortAmy K Ferketich, Joyce C Niland, Rizvan Mamet, et al.
Clinical Lung Cancer|July 1, 2015
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC PatientsErin M Bertino, Terence M Williams, S Patrick Nana-Sinkam, et al.
Pageof 16

Showing results (61-70 of 157) with videos related to

Sort By:
Pageof 16
Clinical Lung Cancer|September 11, 2018
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung CancerDwight H Owen, Lai Wei, Erin M Bertino, et al.
The Journal of Biological Chemistry|January 15, 2004
5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferationWei-Guo Zhu, Theresa Hileman, Yang Ke, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective AnalysisChristian L Barney, Nicholas Scoville, Eric Allan, et al.
Diagnostic Pathology|December 12, 2013
Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumorsKonstantin Shilo, Xin Wu, Smita Sharma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancerRebecca S Heist, Xiaofei Wang, Lydia Hodgson, et al.
Human Pathology|April 22, 2014
Y-chromosome status identification suggests a recipient origin of posttransplant non-small cell lung carcinomas: chromogenic in situ hybridization analysisWei Chen, Sergey V Brodsky, Weiqiang Zhao, et al.
Methods (San Diego, Calif.)|October 5, 2010
The search for an optimal DNA, RNA, and protein detection by in situ hybridization, immunohistochemistry, and solution-based methodsFengting Yan, Xin Wu, Melissa Crawford, et al.
International Journal of Environmental Research and Public Health|August 27, 2014
Clinical and metabolic parameters in non-small cell lung carcinoma and colorectal cancer patients with and without KRAS mutationsAhmet Yilmaz, Nehad Mohamed, Kara A Patterson, et al.
Cancer|October 2, 2012
Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohortAmy K Ferketich, Joyce C Niland, Rizvan Mamet, et al.
Clinical Lung Cancer|July 1, 2015
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC PatientsErin M Bertino, Terence M Williams, S Patrick Nana-Sinkam, et al.
Pageof 16